Home » Pfizer’s Experimental Drug Works in Ulcerative Colitis
Pfizer’s Experimental Drug Works in Ulcerative Colitis
Pfizer’s experimental rheumatoid arthritis pill tofacitinib eased symptoms of patients with ulcerative colitis, an inflammatory bowel disease that affects 750,000 Americans, a company-sponsored study showed.
Businessweek
Businessweek
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May